CSE/NVRS (CSE/NVRS)

Canadian Securities Exchange: CSE/NVRS · CAD

CA$0.05

+0.00 (0.0%)· Recorded snapshot

Market cap	2.6M
Net income (ttm)	1.6M
EPS (ttm)	CA$0.09
Shares out	58.5M
P/E (trailing)	0.5x
Volume	46,643
Beta	-5.51

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): 1.6M
EPS (ttm): CA$0.09
P/E (trailing): 0.5x
Market cap: 2.6M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E0.5

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CSE/NVRS indicators

Market & fundamental data

Available fields

140

Groups with data

Currency

CAD

Showing 140 of 140 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-12-01
Employees change	-8
Employees growth	-72.73%
Enterprise value	CAD 2.2M
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2013
Industry	Agricultural Production Crops
Is primary listing	Yes
ISIN number	CA66990B1085
Last refreshed	2026-10-30
Last stock split date	2025-10-21
Last stock split type	Reverse
Market cap	CAD 2.6M
Next earnings date	2026-12-01
Price	CAD 0.05
Price currency	CAD
SIC code	0100
Stock price date	2026-10-29
Symbol	cse/NVRS
Website	https://noveris.health

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	188.93%
EV/Earnings	1.34x
FCF / EV yield	-65.03%
FCF yield	-54.23%
P/E ratio	0.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-115.47%
ROA (5Y)	-530.46%
ROCE	40.92%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-46.97%
Net income growth	728.07%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
EBIT	CAD -913,048
EPS	CAD 0.09
FCF per share	CAD -0.02
Financing cash flow	CAD 2.2M
Free cash flow	CAD -1.4M
Net borrowing	CAD -69,458
Net cash flow	CAD 808,731
Net income	CAD 1.6M
Operating income	CAD -913,048

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CAD -0.04
Long-term assets	CAD 0
Long-term liabilities	CAD 0
Net cash (debt)	CAD 437,338
Net cash / market cap	16.6%
Piotroski F-Score	1
Shareholders' equity	CAD -2.2M
Tangible book value	CAD -2.2M
Tangible book value per share	CAD -0.04
Total assets	CAD 988,197
Total cash	CAD 808,965
Total debt	CAD 371,627
Total liabilities	CAD 3.2M
WACC	-22.85%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CAD 988,197
Current liabilities	CAD 3.2M
Current ratio	0.31
Net working capital	CAD -2.7M
Quick ratio	0.26
Working capital	CAD -2.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1,461.54%
Shareholder yield	-1,461.54%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-100%
10Y return CAGR	-70.85%
10Y total return	-100%
150-day SMA	CAD 0.95
1D price change	0%
1M price change	-47.06%
1M total return	-47.06%
1W price change	-30.77%
1W total return	-30.77%
1Y price change	-84.75%
1Y return CAGR	-84.77%
1Y total return	-84.75%
20-day SMA	CAD 0.06
200-day SMA	CAD 0.79
3M price change	-96.28%
3M total return	-96.28%
3Y price change	-99.31%
3Y return CAGR	-80.93%
3Y total return	-99.31%
50-day SMA	CAD 0.09
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 3.00
52-week high date	2026-06-01
52-week low	CAD 0.05
52-week low date	2026-10-29
5Y price change	-99.99%
5Y return CAGR	-86.01%
5Y total return	-99.99%
6M price change	-97.75%
6M total return	-97.75%
All-time high	CAD 47,249.94
All-time high date	2017-12-29
All-time low	CAD 0.05
All-time low date	2026-10-23
Average true range (ATR)	CAD 0.01
Average volume	212.7K
Beta (1Y)	-16.42
Beta (2Y)	-11.57
Beta (5Y)	-5.51
Change from 52-week high	-98.5%
Change from 52-week low	0%
Change from all-time high	-100%
Change from all-time low	0%
Change from open	0%
Day's gap	0%
Dollar volume	CAD 2,099
High price	CAD 0.05
Low price	CAD 0.05
Monthly RSI	37.54
Open price	CAD 0.05
Position in 52-week range	0%
Previous close	CAD 0.05
Price vs 150-day SMA	-95.26%
Price vs 20-day SMA	-28.57%
Price vs 200-day SMA	-94.31%
Price vs 50-day SMA	-51.56%
Relative volume	0.22
RSI	27.06
Sharpe ratio	1.17
Sharpe ratio (3Y)	0.92
Sharpe ratio (5Y)	0.53
Sortino ratio	2.33
Sortino ratio (3Y)	1.75
Sortino ratio (5Y)	0.99
Volume	46.6K
Weekly RSI	39.55
YTD price change	-85.48%
YTD total return	-85.48%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	58.5M
Shares change (QoQ)	268.88%
Shares change (YoY)	1,461.54%
Shares outstanding	58.5M

Deeper analysis on CSE/NVRS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/NVRS report

Is a complete CSE/NVRS research report available?

No complete published report is available for cse/NVRS (CSE/NVRS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/NVRS (CSE/NVRS)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/NVRS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/NVRS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/NVRS

Frequently asked questions